Compare ZWS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZWS | BIO |
|---|---|---|
| Founded | 1892 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.1B |
| IPO Year | 2008 | N/A |
| Metric | ZWS | BIO |
|---|---|---|
| Price | $45.28 | $269.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $49.33 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 641.3K | 241.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 25.00 | N/A |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $1,530,500,000.00 | N/A |
| Revenue This Year | $6.90 | $2.51 |
| Revenue Next Year | $5.13 | $3.17 |
| P/E Ratio | $38.92 | ★ $9.72 |
| Revenue Growth | ★ 19.40 | N/A |
| 52 Week Low | $27.74 | $211.43 |
| 52 Week High | $53.17 | $343.12 |
| Indicator | ZWS | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 43.72 |
| Support Level | $45.14 | $266.71 |
| Resistance Level | $45.83 | $289.61 |
| Average True Range (ATR) | 1.29 | 7.99 |
| MACD | -0.58 | 0.10 |
| Stochastic Oscillator | 12.16 | 35.33 |
Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.